A Single-centre, Randomized, Open-label, Three-period Crossover Pharmacokinetic Study of 80 mg Telmisartan / 5 mg Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Amlodipine; Telmisartan
- Indications Essential hypertension; Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 15 Dec 2010 Actual patient number 28 added as reported by ClinicalTrials.gov.
- 15 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.